Vitamin D Supplementation in Pediatrics. Oral or Parenteral! D2 or D3

Ain Shams University120 enrolled

Overview

A study will be performed on Vitamin D deficient/ insufficient Egyptian children to compare the efficacy of oral and parenteral forms of Ergocalciferol and cholecalciferol in raising serum 25(OH) D levels in these subjects

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

120

Conditions

Vitamin D Deficiency

Interventions

vitamin D2, vitamin D3DIETARY_SUPPLEMENT

comparing parentral D2, D3, to oral D2, D3

Eligibility

Sex: ALLMin age: 5 YearsMax age: 10 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * laboratory evidence of vitamin D deficiency or insufficiency without clinical signs of rickets Exclusion Criteria: * vitamin D or calcium supplementation within the last 6 months before inclusion, patients with diabetes mellitus, chronic liver disease and kidney disease, congenital or rheumatic heart disease, malabsorption syndromes, thyroid disease, juvenile rheumatic diseases, or other bone disorders.

Outcomes

Primary Outcomes

serum 25(OH) D level after 1,2,3 months of supplementation

Time frame: 3 months

Central Contacts

Marwa M Nawar, Lecturer

CONTACT

+201005368647 marwa_magdy@med.asu.edu.eg

Heba H ELsedfy, professor

CONTACT

+201005189166 hebased@yahoo.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.